Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Tom Ryu; Young Chang; Seung Up Kim; Jae Young Jang

doi:10.3350/cmh.2025.0179

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Tom Ryu
, Young Chang
, Seung Up Kim
, Jae Young Jang

Department of Internal Medicine

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e203-e205
Journal	Clinical and Molecular Hepatology
Volume	31
Issue number	2
DOIs	https://doi.org/10.3350/cmh.2025.0179
Publication status	Published - 2025 Apr

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hepatology
Molecular Biology

Access to Document

10.3350/cmh.2025.0179

Cite this

@article{dcc33d3feeba4fb89b98f48129efd95e,

title = "Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”",

keywords = "Diabetes mellitus, Direct-acting antivirals, Dyslipidemia, Liver fibrosis, Regression",

author = "Tom Ryu and Young Chang and Kim, \{Seung Up\} and Jang, \{Jae Young\}",

year = "2025",

month = apr,

doi = "10.3350/cmh.2025.0179",

language = "English",

volume = "31",

pages = "e203--e205",

journal = "Clinical and Molecular Hepatology",

issn = "2287-2728",

publisher = "Korean Association for the Study of the Liver",

number = "2",

}

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”. / Ryu, Tom; Chang, Young; Kim, Seung Up et al.
In: Clinical and Molecular Hepatology, Vol. 31, No. 2, 04.2025, p. e203-e205.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy

T2 - A multicenter study for chronic hepatitis C”

AU - Ryu, Tom

AU - Chang, Young

AU - Kim, Seung Up

AU - Jang, Jae Young

PY - 2025/4

Y1 - 2025/4

KW - Diabetes mellitus

KW - Direct-acting antivirals

KW - Dyslipidemia

KW - Liver fibrosis

KW - Regression

UR - https://www.scopus.com/pages/publications/105003002533

UR - https://www.scopus.com/pages/publications/105003002533#tab=citedBy

U2 - 10.3350/cmh.2025.0179

DO - 10.3350/cmh.2025.0179

M3 - Letter

C2 - 39993416

AN - SCOPUS:105003002533

SN - 2287-2728

VL - 31

SP - e203-e205

JO - Clinical and Molecular Hepatology

JF - Clinical and Molecular Hepatology

IS - 2

ER -

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this